S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
OTCMKTS:WNDM

Wound Management Technologies Stock Forecast, Price & News

$28.65
-0.35 (-1.21%)
(As of 11/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$28.00
$28.65
50-Day Range
$29.00
$37.68
52-Week Range
$0.02
$0.10
Volume
3,540 shs
Average Volume
137,966 shs
Market Capitalization
$6.78 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.9
30 days | 90 days | 365 days | Advanced Chart
Receive WNDM News and Ratings via Email

Sign-up to receive the latest news and ratings for Wound Management Technologies and its competitors with MarketBeat's FREE daily newsletter.


Wound Management Technologies logo

About Wound Management Technologies

WNDM Medical Inc. develops, markets, and distributes biotechnology products to physicians, hospitals, and clinics in the United States. The company offers HemaQuell, a resorbable bone hemostat for bone healing; and CellerateRX surgical for healing. The company was formerly known as Wound Management Technologies, Inc. and changed its name to WNDM Medical Inc. in April 2017. WNDM Medical Inc. was founded in 1982 and is based in Fort Worth, Texas.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:WNDM
CUSIP
98211X106
Fax
N/A
Employees
13
Year Founded
N/A

Sales & Book Value

Annual Sales
$5.84 million

Profitability

Net Income
$-600 thousand
Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$6.78 billion
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.27 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -












Wound Management Technologies (OTCMKTS:WNDM) Frequently Asked Questions

Who are Wound Management Technologies' key executives?

Wound Management Technologies' management team includes the following people:
  • Mr. J. Michael Carmena, Chief Exec. Officer (Age 63)
  • Zachary B. Fleming, VP of Sales
  • Sherlene Bagley, Exec. Officer
  • Jay M. Speelhoffer, Director of Strategic Accounts
  • Mr. Michael D. McNeil, Chief Financial Officer (Age 54)

What other stocks do shareholders of Wound Management Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Wound Management Technologies investors own include Bolt Biotherapeutics (BOLT), Abeona Therapeutics (ABEO), OHR Pharmaceutical (OHRP), Synergy Pharmaceuticals (SGYP), Shanta Gold (SHG), Tenet Healthcare (THC), Northern Dynasty Minerals (NAK), OraSure Technologies (OSUR), Isoray (ISR) and I.D. Systems (IDSY).

What is Wound Management Technologies' stock symbol?

Wound Management Technologies trades on the OTCMKTS under the ticker symbol "WNDM."

How do I buy shares of Wound Management Technologies?

Shares of WNDM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Wound Management Technologies' stock price today?

One share of WNDM stock can currently be purchased for approximately $28.65.

How much money does Wound Management Technologies make?

Wound Management Technologies has a market capitalization of $6.78 billion and generates $5.84 million in revenue each year.

How many employees does Wound Management Technologies have?

Wound Management Technologies employs 13 workers across the globe.

What is Wound Management Technologies' official website?

The official website for Wound Management Technologies is www.wmgtech.com.

Where are Wound Management Technologies' headquarters?

Wound Management Technologies is headquartered at 1200 Summit Avenue Suite 414, Fort Worth TX, 76102.

How can I contact Wound Management Technologies?

Wound Management Technologies' mailing address is 1200 Summit Avenue Suite 414, Fort Worth TX, 76102. The company can be reached via phone at 817-529-2300.


This page was last updated on 11/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.